Support investment and innovation in OTCs: ASMI

In its 2016 pre-Budget Submission, ASMI has proposed three regulatory reforms to incentivise investment and innovation in the non-prescription medicines sector and increase consumer access to medicines. “The non-prescription medicines sector (over-the-counter and complementary medicines) requires a regulatory framework balancing consumer protection with an operating environment that incentivises R&D, and investment in new products and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous DDS identifying customers' 'lifestyle age'
Next MAS would support role that already exists: McMaugh